3D Conformal Radiotherapy Tool Speeds Treatment Planning Process
By MedImaging International staff writers Posted on 18 Aug 2011 |
A highly intuitive three-dimensional conformal radiotherapy (3D-CRT) tool lets the clinician evaluate the impact of changing different treatment priorities in real time, which has a large potential to speed up the time-consuming treatment planning optimization process.
RaySearch Laboratories, AB (Stockholm, Sweden) has received an order for its RayStation treatment planning system from The Valley Hospital Cancer Center (Paramus, NJ, USA). Valley will use RayStation as its treatment planning system for 3D-CRT treatments as well as more advanced treatments such as intensity-modulated radiation therapy (IMRT). The order includes functionality covering the full spectrum from all the necessary basic tools needed for patient segmentation and creation of traditional 3D-CRT plans, to advanced tools enabling a more efficient treatment planning process, such as multicriteria optimization.
“When it came time to upgrading our treatment planning system, we took into consideration several different factors. As a busy community hospital, we needed a solution for today and for the future, and RayStation was able to provide this solution while at the same time delivering a product with innovative functionality, performance, and flexibility. By being a PC [personal computer]-based treatment planning system, the cost for future upgrades will be both predictable and controllable,” stated Julie Lo, physicist and clinical supervisor at Valley Hospital Cancer Center. “However, more importantly, it was the innovative functionality that RayStation provides, like multicriteria optimization, built-in tools for IMRT plan analysis, deformable registration, and plan summation, 3D-CRT optimization, adaptive 4D radiotherapy, along with the tried and true DMPO [direct machine parameter optimization], that convinced us to choose this solution. We are excited for the future with RayStation.”
Valley will begin the implementation of RayStation in August 2011, with the intention of going clinical by the end of October 2011. “We are excited to have Valley Community Hospital as our newest customer. Valley’s drive to implement the latest technologies in IMRT and IGRT [image-guided radiation therapy), providing excellent care to their patients, was obvious throughout our discussions. It is a great thing to have large academic institutions using RayStation, but it is especially satisfying to see that our product is being selected at community hospitals as well as private, free standing centers,” noted Marc Mlyn, president of RaySearch Americas.
Johan Lof, CEO of RaySearch Laboratories, AB, said, “The fact that Valley has selected RayStation for its cutting edge technology is another confirmation that the demand for our advanced treatment planning system is rapidly increasing.”
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multicriteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and volumetric-modulated arc therapy (VMAT) optimization and highly accurate dose engines for both photon and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. To date, 15 products have been launched through partners and RaySearch’s software is used at some 1,800 clinics in more than 30 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm.
Related Links:
RaySearch Laboratories
RaySearch Laboratories, AB (Stockholm, Sweden) has received an order for its RayStation treatment planning system from The Valley Hospital Cancer Center (Paramus, NJ, USA). Valley will use RayStation as its treatment planning system for 3D-CRT treatments as well as more advanced treatments such as intensity-modulated radiation therapy (IMRT). The order includes functionality covering the full spectrum from all the necessary basic tools needed for patient segmentation and creation of traditional 3D-CRT plans, to advanced tools enabling a more efficient treatment planning process, such as multicriteria optimization.
“When it came time to upgrading our treatment planning system, we took into consideration several different factors. As a busy community hospital, we needed a solution for today and for the future, and RayStation was able to provide this solution while at the same time delivering a product with innovative functionality, performance, and flexibility. By being a PC [personal computer]-based treatment planning system, the cost for future upgrades will be both predictable and controllable,” stated Julie Lo, physicist and clinical supervisor at Valley Hospital Cancer Center. “However, more importantly, it was the innovative functionality that RayStation provides, like multicriteria optimization, built-in tools for IMRT plan analysis, deformable registration, and plan summation, 3D-CRT optimization, adaptive 4D radiotherapy, along with the tried and true DMPO [direct machine parameter optimization], that convinced us to choose this solution. We are excited for the future with RayStation.”
Valley will begin the implementation of RayStation in August 2011, with the intention of going clinical by the end of October 2011. “We are excited to have Valley Community Hospital as our newest customer. Valley’s drive to implement the latest technologies in IMRT and IGRT [image-guided radiation therapy), providing excellent care to their patients, was obvious throughout our discussions. It is a great thing to have large academic institutions using RayStation, but it is especially satisfying to see that our product is being selected at community hospitals as well as private, free standing centers,” noted Marc Mlyn, president of RaySearch Americas.
Johan Lof, CEO of RaySearch Laboratories, AB, said, “The fact that Valley has selected RayStation for its cutting edge technology is another confirmation that the demand for our advanced treatment planning system is rapidly increasing.”
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multicriteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and volumetric-modulated arc therapy (VMAT) optimization and highly accurate dose engines for both photon and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. To date, 15 products have been launched through partners and RaySearch’s software is used at some 1,800 clinics in more than 30 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm.
Related Links:
RaySearch Laboratories
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
MRI
view channel
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read more
New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more
AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read more
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more